Results 101 to 110 of about 6,869 (208)

Pharmacokinetics of Anidulafungin in Pleural Fluid during the Treatment of a Patient with Candida Empyema

, 2011
Candida empyema is a serious complication of disseminated candidiasis. However, little is known about the intrapleural pharmacokinetics of echinocandins. We report the penetration of anidulafungin into the pleural fluid of a patient with
A. John Barrett, Thomas J. Walsh, Juan Gea-Banacloche, Adrian M. Zelazny, Michael G. Rinaldi, Scott R. Penzak, Robert L. Danner, Marisa Ditullio, Gennethel Pennick, Brad Moriyama, Eleanor Wilson, Stacey A. Henning   +11 more
core   +1 more source

Fast detection of synergy and antagonism in antifungal combinations used against Candida albicans clinical isolates

Scientific Reports
The rise in antifungal resistance has limited treatment options for serious fungal infections, emphasizing the need for effective combination therapies. However, low-cost and rapid systems to evaluate synergy and antagonism in antifungal combinations are
Hanna Lundvik, Ramona Santini, Tugce Unalan Altintop, Volkan Özenci, Dan I. Andersson, Nikos Fatsis-Kavalopoulos   +5 more
doaj   +1 more source

The in vitro efficacy of Anidulafungin with and without Nikkomycin Z against C. auris isolates.

This thesis investigates the in vitro antifungal efficacy of anidulafungin alone and in combination with nikkomycin Z against 15 Candida auris isolates representing four major genetic clades. Candida auris is a multidrug-resistant pathogen posing serious
Amano, Chiaki
core  

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata

, 2012
The aim of this study was to compare the in vitro and in vivo activities of micafungin, caspofungin, and anidulafungin against Candida glabrata. The MICs against 28 clinical isolates showed that the overall susceptibilities to caspofungin and to ...
Orlando F., Manso E., Spreghini E., Giannini D., Posteraro B., Posteraro, Brunella, BARCHIESI, FRANCESCO, Sanguinetti, Maurizio, Sanguinetti M.   +8 more
core   +1 more source

Anidulafungin - A new therapeutic option for candida infections in liver transplantation

, 2012
Introduction: In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for
Bianco G., Grossi U., Agnes S., Frongillo F., Cozza V., Lirosi M. C., Pepe G., Sganga G., Nure E.   +8 more
core   +1 more source

An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America

, 2014
Incidence and mortality of candidaemia/invasive candidiasis (C/IC) is relatively high in Latin America versus North America and Europe. To assess efficacy and safety of intravenous (IV) anidulafungin in Latin American adults with documented C/IC.
Nucci, Marcio, Colombo, Arnaldo L. [UNIFESP], Abreu, Paula, Magana, Martin, Petti, Marco, Schlamm, Haran T., Sanchez, Sonia P.   +6 more
core   +1 more source

Dynamics of Anidulafungin use in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2014
Zeliha Kocak Tufan, Rahmet Guner, Tumer Guven, Gul Ruhsar Yilmaz, Mehmet A. Tasyaran   +4 more
doaj   +1 more source

In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of <i>Candida</i> (<i>Candidozyma</i>) <i>auris</i>. [PDF]

J Fungi (Basel)
Balázsi D, Meis JF, Locke JB, Udvarhelyi G, Tóth Z, Forgács L, Kósa C, Kovács R, Majoros L.   +8 more
europepmc   +1 more source

DP042 | IMPACT OF ANTIFUNGAL PROPHYLAXIS ON TRANSPLANT-RELATED MORTALITY IN MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT): A PROSPECTIVE EXPERIENCE FROM A SINGLE TRANSPLANT PROGRAM

Haematologica
Background In the allogeneic HSCT, the incidence of Invasive Fungal Disease is 7-9% with high rate of mortality. Although the antifungal prophylaxis is crucial, the role of anidulafungin is unknown.
A. Carobene, M. Pedata, M. Celentano, T. Ascione, C. Riccardi, S. Marotta, S. Leone, I. Migliaccio, C. Luise, U. De Martino, V. Oliva, S.M. Muggianu, M. Boccola, D. Buonanno, C. Falco, L. Altomare, A. Zuccarelli, M. Toriello, R. Penta, and A. Picardi   +19 more
doaj  

Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting. [PDF]

J Bone Jt Infect
Richards AJ, Asif A, Ivan M, Lillie PJ, Barlow G, Walsh C.   +5 more
europepmc   +1 more source